industry. The US-based pharma major Pfizer on Wednesday ceased operations at its manufacturing units in Aurangabad in Maharashtra and Chennai due to long-term l. ... More Latest News… US pharma major Pfizer is said to have formulated a compensation package for its workers at Chennai and Aurangabad production facilites which are being closed down by the company due to the lack of commercial viability. The closure is likely to impact nearly 1,700 workers. Track the industry of your choice with a daily newsletter specific to that industry. The IKKT unit manufactured generic injectable cephalosporin, penems, and penicillin for the US, the EU and rest of the world markets. Beautifully designed, slim, and sporting a good set of cameras at an affordable price, This latest Mi Band can rival any smartwatch in terms of the number of features it offers. US pharma major Pfizer Inc has decided to shut down its manufacturing units in Irungattukottai, Chennai and Aurangabad, Maharashtra, which came to it through an acquisition of injectables manufacturer Hospira in 2015. Press Kits @Pfizer @Pfizer_News. By Gireesh Babu & T E Narasimhan | The two plants had come into the Pfizer fold through its international acquisition of Hospira. Please Subscribe to get access to one of our early bird packs. 2020The Indian Express [P] Ltd. All Rights Reserved. Pfizer's manufacturing facility in Tamil Nadu’s Sriperumbudur is not following quality control norms and lacks data related to laboratory records. The closure is likely to impact nearly 1,700 workers. Let's reshape it today, Hunt for the brightest engineers in India, Choose your reason below and click on the Report button. The company's Vizag site is being expanded into a global terminally sterilised manufacturing centre of excellence. Last year, the IKKT plant had “paused” production after it came in for a regulatory rap from the USFDA. “As a result, Pfizer is announcing that both the Aurangabad and Irungattukottai sites will immediately cease manufacturing with the intention to exit both sites as soon as possible in 2019. CHENNAI: US-drug maker Pfizer will be shutting down two of its facilities in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing non-viability of operations. Pfizer to Present Latest Scientific Advancements from Its Industry- Leading Portfolio at the ESMO Virtual Congress 2020. view all press releases & statements. Pfizer’s own vintage plant in Thane was also sold about three years ago. Stay on top of your investments. We are not able to provide additional details at this point,” the spokesperson said. Featured Stories. The company however said that the exact timing of the exit of the sites... 09 Jan, 2019, 05.57 PM IST. Aurangabad supports IKKT by supplying penems and penicillin. Podcasts. At present, its Irungattukottai unit in Tamil Nadu employs approximately 1,000 workers and the Aurangabad site in … As a result, Pfizer is announcing that both the Aurangabad and IKKT sites will immediately cease manufacturing with the intention to exit both sites as soon as possible in 2019,” said a Pfizer spokesperson. Chennai | Mumbai Last Updated at January 08 2019 22:59 IST, First Published: Tue,January 08 2019 22:58 IST, Plans are also afoot to expand the Vizag manufacturing facility of the company. Over 1,700 employees working in these two factories are expected to be impacted by the decision. Pfizer said that it conducted a thorough evaluation of the Irungattukottai and Aurangabad sites and concluded that due to a significant fall in product demand, manufacturing at these sites is not viable. Follow us on Telegram, Remembering APJ Abdul Kalam’s ‘Vision 2020’ on his birth anniversary; where does Indian economy stand? Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. The US pharma company had secured these plants when it acquired Hospira in 2015. US-drug gaint Pfizer will be soon be shutting down two of its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.. Pfizer to stop manufacturing at its Chennai and Aurangabad facilities. Featured Stories. by pfizer. by pfizer. All Filters. Get to Know Us. The closures will affect 1700 employed at both locations of the company which has a total of five manufacturing sites across the country. Like us on Facebook and follow us on Twitter. Digital Editor. The Irungattukottai facility currently employs around 1,000 people and Aurangabad site employs around 700. Bangladesh, Bhutan may beat India on economic front; worst GDP contraction threat looms, Amazon Great Indian Festival Sale top smartphone deals: iPhone 11 under Rs 50,000, OnePlus 8 5G under Rs 40,000 and more, Legends of Indo-Tibet relations: Amidst India-China standoff, a look at the ancient trans-Himalayan bond, Cinema theatres set to resume operations this week, several releases lined up, Cabinet to soon consider new public sector enterprises policy: Sources, Centre mandates all ministries, public depts, CPSUs to use BSNL, MTNL services, Why govt employees may not opt for LTC cash voucher scheme; SBI Research lists out major roadblocks, 'Bangladesh set to overtake India': Rahul Gandhi targets Centre over IMF projections on per capita GDP, Indian Railways boost for Make in India! I am a 53-year-old home-maker. Also read: RIL Q3 net profit beats estimate: Here’s what Mukesh Ambani has to say. Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. Digital currency: World is learning from China; India must not stay behind, Economists are starting to think like engineers, Den Networks Q2 consolidated net profit declines 61.4% to Rs 36 cr, Best of BS Opinion: Tanishq ad row, Bangladesh's per capita GDP, and more, LIVE: Rise in pollution amid Covid pandemic could be fatal, says Delhi CM, Tripura coronavirus update: State reports 181 fresh Covid-19 cases, Meet with Punjab farmers set at secy level; govt open for talks: Agri Min, Attorney General not in favour of appealing against Voda arbitration award, Pandemic shock forced me to exit retail biz: Future Group founder Biyani, Infosys outshines rivals with Q2 performance; net profit jumps 20.5%, Set for muted opening after 7-month closure, theatres eye Diwali fireworks, Is compensation paid by employer taxable?